MR1 presentation of vitamin B-based metabolite ligands

作者：McWilliam Hamish E G; Birkinshaw Richard W; Villadangos Jose A; McCluskey James^*; Rossjohn Jamie

来源：Current Opinion in Immunology, 2015, 34: 28-34.

DOI：10.1016/j.coi.2014.12.004

The major histocompatibility complex class l-related molecule MR1 can bind a novel class of antigens, namely a family of related small organic vitamin B metabolites. When bound to MR1 these metabolites are presented to a population of innate-like T cells, mucosal-associated invariant T (MAIT) cells that express a semi-invariant T cell receptor (TCR). Several non-activating and activating MR1-restricted ligands have been described, which are the degradation products of, or intermediates of, vitamin B-9 (folic acid) or vitamin B-2 (riboflavin), respectively. The MAIT-activating intermediates of the riboflavin synthesis pathway are unique to a wide range of microbes, and accordingly represent a molecular signature of microbial infection. Recently insights into the binding of these vitamin B metabolites to MR1, and subsequent recognition by the MAIT TCR, have been gleaned, illustrating a novel antigen presentation system.

• 出版日期2015-6